Acasti Pharma Inc. (ACST) SEC Filing 20-F Annual report for the fiscal year ending Sunday, March 31, 2019

Document And Entity Information

Statements Of Cash Flows (Twelve Month And Month Ended 2017 Unaudited)

Statements Of Changes In Equity (Twelve Month And Month Ended 2017 Unaudited)

Statements Of Changes In Equity (Twelve Month And Month Ended 2017 Unaudited) (Parentheticals)

Statements Of Earnings And Comprehensive Loss (Twelve Month And Month Ended 2017 Unaudited)

Statements Of Financial Position

Note 1 - Reporting Entity

Note 10 - Intangible Assets

Note 10 - Intangible Assets (Tables)

Note 10 - Intangible Assets - Components Of Intangible Assets (Details)

Note 11 - Trade And Other Payables

Note 11 - Trade And Other Payables (Tables)

Note 11 - Trade And Other Payables - Components Of Trade And Other Payables (Details)

Note 12 - Derivative Warrant Liabilities

Note 12 - Derivative Warrant Liabilities (Details Textual)

Note 12 - Derivative Warrant Liabilities (Tables)

Note 12 - Derivative Warrant Liabilities - Assumptions (Details)

Note 12 - Derivative Warrant Liabilities - Reconciliation (Details)

Note 13 - Unsecured Convertible Debentures

Note 13 - Unsecured Convertible Debentures (Details Textual)

Note 13 - Unsecured Convertible Debentures (Tables)

Note 13 - Unsecured Convertible Debentures - Liability And Equity Component Portions (Details)

Note 14 - Capital And Other Components Of Equity

Note 14 - Capital And Other Components Of Equity (Details Textual)

Note 14 - Capital And Other Components Of Equity (Tables)

Note 14 - Capital And Other Components Of Equity - Assumptions (Details)

Note 14 - Capital And Other Components Of Equity - Unsecured Convertible Debentures (Details)

Note 14 - Capital And Other Components Of Equity - Warrants Outstanding (Details)

Note 15 - Personnel Expenses

Note 15 - Personnel Expenses (Tables)

Note 15 - Personnel Expenses - Components Of Personnel Expenses (Details)

Note 16 - Financial Expenses

Note 16 - Financial Expenses (Tables)

Note 16 - Financial Expenses - Components Of Finance Income (Expenses) (Details)

Note 17 - Share-Based Payments

Note 17 - Share-Based Payments (Details Textual)

Note 17 - Share-Based Payments (Tables)

Note 17 - Share-Based Payments - Option Activity (Details)

Note 17 - Share-Based Payments - Outstanding And Exercisable Options (Details)

Note 17 - Share-Based Payments - Weighted Average Assumptions (Details)

Note 18 - Loss Per Share

Note 19 - Supplemental Cash Flow Disclosure

Note 19 - Supplemental Cash Flow Disclosure (Tables)

Note 19 - Supplemental Cash Flow Disclosure - Changes In Non-Cash Operating Items (Details)

Note 19 - Supplemental Cash Flow Disclosure - Non-Cash Transactions (Details)

Note 2 - Basis Of Preparation

Note 2 - Basis Of Preparation (Details Textual)

Note 20 - Income Taxes

Note 20 - Income Taxes (Details Textual)

Note 20 - Income Taxes (Tables)

Note 20 - Income Taxes - Deferred Tax (Recovery) Expense (Details)

Note 20 - Income Taxes - Reconciliation Of Effective Tax Rate (Details)

Note 20 - Income Taxes - Tax Attributes And Temporary Differences Available To Reduce Future Years' Taxable Income (Details)

Note 20 - Income Taxes - Unrecognized Deferred Tax Assets (Details)

Note 21 - Financial Instruments

Note 21 - Financial Instruments (Tables)

Note 21 - Financial Instruments - Currency Risk (Details)

Note 21 - Financial Instruments - Financial Liabilities (Details)

Note 22 - Commitments And Contingencies

Note 22 - Commitments And Contingencies (Details Textual)

Note 23 - Determination Of Fair Values

Note 23 - Determination Of Fair Values (Details Textual)

Note 24 - Capital Management

Note 24 - Capital Management (Details Textual)

Note 24 - Capital Management (Tables)

Note 24 - Capital Management - Cash And Cash Equivalents (Details)

Note 24 - Capital Management - Cash And Cash Equivalents (Details) (Parentheticals)

Note 25 - Subsequent Events

Note 25 - Subsequent Events (Details Textual)

Note 3 - Significant Accounting Policies

Note 3 - Significant Accounting Policies (Details Textual)

Note 3 - Significant Accounting Policies (Tables)

Note 3 - Significant Accounting Policies - Estimated Useful Lives And Rates (Details)

Note 4 - Receivables

Note 4 - Receivables (Tables)

Note 4 - Receivables - Schedule Of Receivables (Details)

Note 5 - Marketable Securities

Note 5 - Marketable Securities (Tables)

Note 5 - Marketable Securities - Marketable Securities (Details)

Note 5 - Marketable Securities - Marketable Securities (Details) (Parentheticals)

Note 6 - Other Assets

Note 6 - Other Assets (Tables)

Note 6 - Other Assets - Other Assets (Details)

Note 7 - Related Parties

Note 7 - Related Parties (Details Textual)

Note 7 - Related Parties (Tables)

Note 7 - Related Parties - Administrative And Research And Development Expenses (Details)

Note 7 - Related Parties - Key Management Personnel Compensation (Details)

Note 8 - Government Assistance

Note 8 - Government Assistance (Tables)

Note 8 - Government Assistance - Government Grants And Investment Tax Credits (Details)

Note 8 - Government Assistance - Unrecognized Federal Tax Credits (Details)

Note 9 - Equipment

Note 9 - Equipment (Tables)

Note 9 - Equipment - Components Of Equipment (Details)

Significant Accounting Policies (Policies)